EpiVax, Inc.: Dr. Anne De Groot Appears on "Amazing Women" Radio Show

News

EpiVax, Roche Team Up to Develop Tregitope Technology - December 2009

EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology - December 2009

Providence’s Jewelry District: Growth hotspot? - November 2009

Polly Matzinger Fearless Scientist Award - November 2009

Boston Herald Business News: Annie De Groot Proves the Power of One Person - October 2009

Open Registration for Spring 2010 URI Class - September 2009

EpiVax, De Groot focus of WRNI feature on biotech and the "knowledge economy" - August 2009

Cicilline cites EpiVax as socially-conscious company - August 2009

Mass High Tech Business News: De Groot wins $13M NIH Grant - July 2009

Providence Business News: De Groot wins $13M NIH grant - July 2009

Providence Journal: URI wins $13-million federal grant for vaccine research - July 2009

URI researcher awarded $13 million grant for development of vaccines for emerging infectious diseases - July 2009

EpiVax Research to be Presented at Numerous Conferences this Autumn - July 2009

Providence Business News profiles Dr. Anne De Groot - June 2009

Dr. De Groot honored at PBN Business Women Awards luncheon - May 2009

Dr. Anne De Groot Appears on "Amazing Women" Radio Show - May 2009

Annie De Groot Presents to NIH/NIAID on Next Generation Epitope-Driven Vaccines - May 2009

Dr. Annie De Groot chosen for PBN Overall Career Achievement Award - April 2009

Daughter, Father Reunite at URI Lab - February 2009

New lab will research vaccines - February 2009

URI taps De Groot to head new vaccine research center - February 2009

EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery - December 2008

EpiVax Profiled as "Tech Firm in RI to Watch" - November 2008

EpiVax Receives Tech Citizenship Award from Mass High Tech - October 2008

Publication on “Tregitopes” in Blood Journal of October 2008 - October 2008

Dr. Annie De Groot, CEO, awarded YWCA 2008 Women of Achievement Award - September 2008

EpiVax awarded $35K Montel Williams Foundation grant for multiple sclerosis research - September 2008

EpiVax Recieves $600,000 NIH Grant to Further Research in Type 1 Diabetes - September 2008

EpiVax Presents Tolerance-inducing "Tregitopes" at Keystone Conference - January 2008

EpiVax Receives JDRF Industry Program Funding to Develop Diabetes Drug Using Natural "regulatory" T cells - October 2007

EpiVax awarded $590,000 SBIR for Immunoinformatics-driven TB Vaccine - September 2007

EpiVax Awarded a Grant for Hemophilia Therapy - July 2007

EpiVax funded to advance research on a new, improved “Botox” - March 2007

EpiVax wins SBIR Phase I grant totaling $993,771 to Develop Smallpox Vaccine - June 2005

EpiVax Is Awarded H. Pylori SBIR Grant by National Institutes of Health - June 2005

EpiVax moves to new facility at 146 Clifford Street including office and laboratory space - November 2004

EpiVax wins SBIR Phase I grant totaling $859,773 to Develop Tularemia Vaccine - September 2004

EpiVax signs Master Services Agreement with Amgen - July 2004

EpiVax renews technology license with Brown University - August 2003

EpiVax receives $150,000 in phase II funding from Slater Center for Bio-Technology - March 2003

EpiVax signs Master Services Agreement with Brown University - March 2003

EpiVax signs Laboratory Services Agreement with Eli Lilly - March 2002

Awarded SBIR Phase I grant for West Nile Virus diagnostic project - September 2001

Awarded SBIR Phase I grant for Human Papiloma Virus vaccine project - September 2001

Signed strategic cooperation and co-marketing agreement with Beckman Coulter Immunomics - June 2001

Anne De Groot named Core Scientist by Sequella Global TB Foundation and awarded 3 year $900,000 TB vaccine development grant - April 2000

Awarded SBIR Phase I for HIV vaccine development. Full time operations begin. - September 1999

Awarded phase 1 development grant from Rhode Island’s Slater Center for Biomedical Technology - June 1998

EpiVax, Inc. founded by Dr. Anne De Groot - May 1998

May 2009

Dr. Anne De Groot Appears on "Amazing Women" Radio Show

Dr. Anne De Groot and Amazing Women host Deb Ruggiero talk about immunology, immunoinformatics, and diabetes research. The program is split into two segments, each 11 minutes long. (Player requires Flash and JavaScript)

Previous Next